Collectively, these results suggest that Sox9 contributes to the miR-133b-endowed suppression of tumorigenic and metastatic ability of breast cancer cells, whereas WAVE2 only has effect on the cell motility suppression caused by miR-133b. Here, WASF2 is linked to breast carcinoma.